|
Doxazosin MesylateDrug - Doxazosin Mesylate The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Doxazosin Mesylate
Strength -
EQ 4MG BASE
Applicant -
WATSON LABS
New Drug Application (NDA) Number -
075426
Product Number -
003
Therapeutic Equivalence (TE) Code -
AB
Approval Date -
Oct 18, 2000
Reference Listed Drug (RLD) -
No
Type -
RX
Applicant Full Name -
Watson Laboratories Inc
Doxazosin Mesylate
Doxazosin Mesylate Eq 4mg Base Tablet; Oral
Doxazosin Mesylate Eq 8mg Base Tablet; Oral Doxazosin Mesylate Eq 1mg Base Tablet; Oral Doxazosin Mesylate Eq 2mg Base Tablet; Oral Doxazosin Mesylate Eq 4mg Base Tablet; Oral Doxazosin Mesylate Eq 4mg Base Tablet; Oral Doxazosin Mesylate Eq 8mg Base Tablet; Oral Doxazosin Mesylate Eq 8mg Base Tablet; Oral Doxazosin Mesylate Eq 1mg Base Tablet; Oral Doxazosin Mesylate Eq 2mg Base Tablet; Oral NewDrugInformation |